Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.54
Bid: 53.00
Ask: 54.74
Change: 0.00 (0.00%)
Spread: 1.74 (3.283%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 54.54
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplementary Prospectus

29 Jul 2021 15:11

RNS Number : 9631G
Lloyds Banking Group PLC
29 July 2021
 

29 July 2021

 

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 29 July 2021 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with the base prospectus dated 17 June 2021 (together, the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:http://www.rns-pdf.londonstockexchange.com/rns/9631G_1-2021-7-29.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations Director 

Tel: +44 20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

Corporate Affairs:

 

Matt Smith

Head of Corporate Media

Tel: +44 20 7356 3522

E-mail: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburghEH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPEALXNAEXFEFA
Date   Source Headline
27th Apr 20205:05 pmRNSDisclosure of rights attached to listed securities
23rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20202:00 pmRNSDirector/PDMR Shareholding
8th Apr 20206:30 pmRNSLloyds Bank C$ Buyback
8th Apr 20204:42 pmRNSSecond Price Monitoring Extn
8th Apr 20204:36 pmRNSPrice Monitoring Extension
7th Apr 202010:43 amRNSCash Tender Offer - 12% Capital Securities
7th Apr 202010:11 amRNSCash Tender Offer - Outstanding Senior Notes
7th Apr 20207:00 amRNSCash Tender Offer - Outstanding Senior Notes
1st Apr 20204:01 pmRNSPublication of Final Terms
1st Apr 20207:00 amRNSUpdate on Dividend Payments
31st Mar 20202:00 pmRNSTotal Voting Rights
31st Mar 202012:38 pmRNSCash Tender Offer - 12% Capital Securities
30th Mar 20204:58 pmRNSCash Tender Offer - Outstanding Senior Notes
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20202:00 pmRNSDirector/PDMR Shareholding
20th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20201:36 pmRNSNotice of AGM
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20202:00 pmRNSDirector/PDMR Shareholding
17th Mar 20208:10 amRNSPublication of Final Terms
16th Mar 202011:21 amRNSDirector Declaration
16th Mar 20209:30 amRNSDirector Declaration
12th Mar 20202:00 pmRNSDirector/PDMR Shareholding
11th Mar 202011:29 amRNSSubordinated Debt Exchange Offer Results
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSSubordinated Debt Exchange Offer
28th Feb 20202:27 pmRNSTotal Voting Rights
26th Feb 202012:47 pmRNSDirector Declaration
26th Feb 202010:36 amRNS2019 Annual Report on Form 20-F
25th Feb 20207:00 amRNSBlock Listing of Shares
20th Feb 202012:59 pmRNSPublication of Supplementary Prospectus
20th Feb 20207:00 amRNS2019 Full Year Results
20th Feb 20207:00 amRNS2019 Annual Report and Accounts
20th Feb 20207:00 amRNS2019 Full Year Results
20th Feb 20207:00 amRNS2019 Annual Report and Accounts
12th Feb 20202:00 pmRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
15th Jan 20205:06 pmRNSPublication of Final Terms dated 13 January 2020
13th Jan 20202:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20202:37 pmRNSBlock listing Interim Review
31st Dec 201911:00 amRNSTotal Voting Rights
30th Dec 20192:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.